ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
Provided By PR Newswire
Last update: Jul 1, 2025
LAUSANNE, Switzerland, July 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 17,000 of the Company's common shares to one new employee on July 1, 2025 (each, a "Grant").
Read more at prnewswire.com
